Dashboard
Manage Tickers

GKOSGLAUKOS Corp

NYSE glaukos.com


$ 116.07 $ -1.58 (-1.34 %)    

Friday, 02-Aug-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 116.03
$ 116.01 x 100
-- x --
-- - --
$ 59.22 - $ 126.96
690,538
na
5.88B
$ 1.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-28-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-04-2016 03-31-2016 10-Q
35 03-15-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

glaukos-stock-a-deep-dive-into-analyst-perspectives-12-ratings
Glaukos Stock: A Deep Dive Into Analyst Pe...
08/01/2024 19:07:19

piper-sandler-maintains-overweight-on-glaukos-raises-price-target-to-140
Piper Sandler Maintains Overweight on Glau...
08/01/2024 15:51:45

Piper Sandler analyst Matt O'Brien maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $110...

wells-fargo-maintains-overweight-on-glaukos-raises-price-target-to-135
Wells Fargo Maintains Overweight on Glauko...
08/01/2024 13:45:01

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $120 to...

truist-securities-reiterates-buy-on-glaukos-raises-price-target-to-145
Truist Securities Reiterates Buy on Glauko...
08/01/2024 13:22:45

Truist Securities analyst Richard Newitter reiterates Glaukos (NYSE:GKOS) with a Buy and raises the price target from $141 t...

meta-to-rally-around-35-here-are-10-top-analyst-forecasts-for-thursday
Meta To Rally Around 35%? Here Are 10 Top ...
08/01/2024 12:17:30

needham-maintains-buy-on-glaukos-raises-price-target-to-137
Needham Maintains Buy on Glaukos, Raises P...
08/01/2024 09:32:19

Needham analyst David Saxon maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $131 to $137.

glaukos-sees-fy24-revenue-370m-376m-vs-36302m-est
Glaukos Sees FY24 Revenue $370M-$376M Vs $...
07/31/2024 20:26:06

2024 Revenue GuidanceThe company expects 2024 net sales to be in the range of $370 million to $376 million based on the latest ...

glaukos-q2-adj-052-inline-sales-9569m-beat-8889m-estimate
Glaukos Q2 Adj $(0.52), Inline, Sales $95....
07/31/2024 20:10:51

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.52) per share which met the analyst consensus estimate. This is a 5.45 per...

truist-securities-maintains-buy-on-glaukos-raises-price-target-to-141
Truist Securities Maintains Buy on Glaukos...
07/16/2024 13:38:44

Truist Securities analyst Samuel Brodovsky maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $125 to...

btig-maintains-buy-on-glaukos-raises-price-target-to-131
BTIG Maintains Buy on Glaukos, Raises Pric...
07/15/2024 17:06:49

BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $112 to $131.

morgan-stanley-maintains-equal-weight-on-glaukos-raises-price-target-to-120
Morgan Stanley Maintains Equal-Weight on G...
07/15/2024 16:54:56

Morgan Stanley analyst Patrick Wood maintains Glaukos (NYSE:GKOS) with a Equal-Weight and raises the price target from $100 ...

10-analysts-have-this-to-say-about-glaukos
10 Analysts Have This To Say About Glaukos
07/10/2024 20:00:18

this-visa-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday
This Visa Analyst Is No Longer Bullish; He...
07/10/2024 13:05:59

citigroup-downgrades-glaukos-to-neutral-raises-price-target-to-132
Citigroup Downgrades Glaukos to Neutral, R...
07/10/2024 12:48:07

Citigroup analyst Joanne Wuensch downgrades Glaukos (NYSE:GKOS) from Buy to Neutral and raises the price target from $130 to...

glaukos-corporation-reveals-agreements-to-exchange-230m-in-principal-amount-of-its-275-convertible-senior-notes-due-2027-for-common-stock-these-exchange-transactions-are-expected-to-close-on-or-about-june-25-2024
Glaukos Corporation Reveals Agreements To ...
06/14/2024 11:25:27

Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company, today announced that it entered i...

stifel-maintains-buy-on-glaukos-raises-price-target-to-130
Stifel Maintains Buy on Glaukos, Raises Pr...
06/05/2024 12:46:02

Stifel analyst Thomas Stephan maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $110 to $130.

wells-fargo-maintains-overweight-on-glaukos-raises-price-target-to-120
Wells Fargo Maintains Overweight on Glauko...
06/03/2024 18:35:53

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $110 to...

deep-dive-into-glaukos-stock-analyst-perspectives-12-ratings
Deep Dive Into Glaukos Stock: Analyst Pers...
05/22/2024 18:01:16

citigroup-maintains-buy-on-glaukos-raises-price-target-to-130
Citigroup Maintains Buy on Glaukos, Raises...
05/22/2024 17:26:11

Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $120 to $130.

jefferies-upgrades-glaukos-to-buy-raises-price-target-to-125
Jefferies Upgrades Glaukos to Buy, Raises ...
05/06/2024 12:37:08

Jefferies analyst Michael Sarcone upgrades Glaukos (NYSE:GKOS) from Hold to Buy and raises the price target from $84 to $125.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)